Alyeska Investment Group, L.P. Renovo Rx, Inc. Call Options Transaction History
Alyeska Investment Group, L.P.
- $23.4 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RNXT
# of Institutions
29Shares Held
11MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$4.09 Million1.85% of portfolio
-
Awm Investment Company, Inc. New York, NY2.29MShares$2.7 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.59 Million0.0% of portfolio
-
Bank Of The West975KShares$1.15 Million0.27% of portfolio
-
Bleichroeder LP New York, NY500KShares$590,0000.17% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $10.7M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...